Search

Your search keyword '"Sanchez-Martinez R."' showing total 46 results

Search Constraints

Start Over You searched for: Author "Sanchez-Martinez R." Remove constraint Author: "Sanchez-Martinez R."
46 results on '"Sanchez-Martinez R."'

Search Results

4. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

5. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

6. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

7. Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa registry) in Spain: Objectives, methods, and preliminary results

8. Registro informatizado de la telangiectasia hemorrágica hereditaria (Registro RiHHTa) en España: objetivos, métodos y resultados preliminares

9. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

10. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

11. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

12. Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker in COVID-19 patients: a systematic review.

13. An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome

14. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

15. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

16. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

17. Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study

18. Mortality and Prognostic Factors in Patients over 90 Years of Age Admitted in Internal Medicine: A Spanish Prospective Cohort Study

19. Predictors of active cancer thromboembolic outcomes

20. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

21. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

22. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

23. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

24. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

25. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

30. A Permissive Retinoid X Receptor/Thyroid Hormone Receptor Heterodimer Allows Stimulation of Prolactin Gene Transcription by Thyroid Hormone and 9-cis-Retinoic Acid

31. CARDIOVASCULAR RISK IN WOMEN ATTENDED IN PRIMARY CARE. BASELINE DATA OF THE EVA STUDY.

33. SEX AND AGE DIFFERENCES OF PATIENTS ADMITTED TO GENERAL INTERNAL MEDICINE WARD IN SPAIN: A CROSS-SECTIONAL RETROSPECTIVE STUDY OF 13 YEARS

36. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

37. Contribuciones para el desarrollo sostenible de la cuenca del lago de Cuitzeo, Michoacan

38. Contribuciones para el desarrollo sostenible de la cuenca del lago de Cuitzeo, Michoacan

39. Contribuciones para el desarrollo sostenible de la cuenca del lago de Cuitzeo, Michoacan

40. Association of Human Leukocyte Antigen Alleles with COVID-19 Severity and Mortality in a Spanish Population.

41. Severe Spontaneous Hematomas in Patients Hospitalized with COVID-19.

42. Description of two cultivated and two uncultivated new Salinibacter species, one named following the rules of the bacteriological code: Salinibacter grassmerensis sp. nov.; and three named following the rules of the SeqCode: Salinibacter pepae sp. nov., Salinibacter abyssi sp. nov., and Salinibacter pampae sp. nov.

43. Association between Clinical Frailty Scale (CFS) and clinical presentation and outcomes in older inpatients with COVID-19.

44. Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.

45. Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study.

46. Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role.

Catalog

Books, media, physical & digital resources